COLUMBIA, Md., Aug. 14 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced that it intends to release the results of its third quarter of fiscal 2007 on September 5, 2007, at approximately 4:00 p.m. Eastern Daylight Time (EDT). Following the release, at 4:45 p.m. EDT Martek will hold a conference call to discuss the results of its third quarter of fiscal 2007 with investors. The call is expected to be approximately one hour in duration. The conference call will also be available live via the Internet. All interested parties may listen to the call by visiting Martek’s web site at http://investors.martek.com.
An archived webcast of the conference call will be available on the Martek’s website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 and entering pass code 21344626.
Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life’sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life’sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com.
Contact: Kyle Stults Investor Relations (410) 740-0081 Cassie France-Kelly Public Relations (410) 740-0081
Martek Biosciences Corporation
CONTACT: Kyle Stults, Investor Relations, or Cassie France-Kelly, PublicRelations, both for Martek Biosciences Corporation, +1-410-740-0081
Web site: http://www.martek.com/
